Show simple item record

dc.contributor.author Ginju, Nadia
dc.date.accessioned 2020-07-07T11:50:57Z
dc.date.available 2020-07-07T11:50:57Z
dc.date.issued 2016
dc.identifier.citation GINJU, Nadia. Multidimendional approach to exacerbation of COPD. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p. 108. en_US
dc.identifier.isbn 978-9975-3028-3-8.
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/11077
dc.description Division of Respiratory Medicine, Department of Internal medicine, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016 en_US
dc.description.abstract Introduction: Chronic obstructive pulmonary disease (COPD) is not only an established major cause of mortality and morbidity but is increasing in worldwide prevalence despite current medical interventions. Excerbation of chronic obstructive pulmonary disease has a negative impact on mortality, quality of life, leading to limitation of physical activity and also presents a significant burden. One of the tools for risk stratification of COPD exacerbation is BAP-65 which includes: elevated blood urea nitrogen, alterated mental status, pulse > 109 beats/ minute, age > 65 years. Objective of the study is to estimate the mortality risk of patients with COPD exacerbation using the BAP-65 score. Materials and methods: We have evaluated 106 patients with COPD exacerbation, who were hospitalized in Institue of Phtysiopneumology ”Chiril Draganiuc” between 2014-2016. The average age being 65.5 ± 3.8 years. We analyzed spirometry data, BAP-65 score, 6 minute walking test and quality of life was assessed by CAT test. Results: The obtained data of the study group demonstrated the predominance of men 84 (80%) versus women 22 (20%). In the study group as BAP-65 score the pacients were divided into 5 clases. The more patients were clasiffied as class III – 36 (33.9%) and class I - ( 31.1%). The BAP-65 score determinated the mortality risk in our study – 33 (31,1%) patients have a probable mortality risk of 0,50%, 19(17,9%) cases – mortality risk is 1,4%, 36(33,9%) cases have a mortality risk of 3,7%. A higher mortality risk of 13% have 16 (15,09%) patients and only 4(3,7%) patients have a probable mortality risk of 26,20%. We perfomed correlation analysis between BAP-65 score and quality of life, exacerbations rate, 6-minute walk test. The BAP-65 score had strong correlation with quality of life assessed by CAT (r=0.83, p <0.01) and good correlation with exacerbations rate ( r = 0.62, p <0.01). We did not find any statistically significant correlation between BAP-65 score and 6 minute walk test distance (r = -0.09, p <0.001). Conclusion: The BAP-65 score is a simple tool for multidimensional assessment of COPD exacerbation. The BAP-65 score correlates strong with rate of COPD exacerbation and quality of life assessed by CAT. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject Exacerbation en_US
dc.subject BAP-65 score en_US
dc.subject CAT test en_US
dc.subject mortality risk en_US
dc.title Multidimendional approach to exacerbation of COPD en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2016
    The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics